Sleep disorders in Parkinson’s disease

被引:0
作者
Cynthia L. Comella
机构
[1] Rush University Medical Center,Department of Neurological Sciences
来源
Current Treatment Options in Neurology | 2008年 / 10卷
关键词
Multiple System Atrophy; Excessive Daytime Sleepiness; Rotigotine; Periodic Limb Movement; Multiple Sleep Latency Test;
D O I
暂无
中图分类号
学科分类号
摘要
Sleep disorders in Parkinson’s disease (PD) are frequent and have numerous etiologies. Both nighttime sleep disturbances and daytime sleepiness can occur. The key to effective treatment is appropriate diagnosis. A careful interview of the patient and his or her bed partner provides direction for additional evaluations. Referral to a sleep specialist for quantitative studies is necessary to evaluate for rapid eye movement (REM) sleep behavior disorder, sleep apnea, periodic limb movements, and other sleep disorders. Excessive daytime sleepiness may be attributed to interrupted nighttime sleep or daytime medications (particularly the dopamine agonists) or it may be intrinsic to PD. When the diagnosis is established, treatment is directed toward the primary sleep disturbance. Fragmented sleep due to recurrence of PD symptoms may improve with the use of long-acting preparations of carbidopa/levodopa. Sleep apnea is treated using continuous positive airway pressure, and REM sleep behavior disorder may improve using pharmacologic interventions, although controlled trials are lacking. Restless legs syndrome and periodic limb movements during sleep are treated with direct dopaminergic agonists at bedtime. Excessive daytime sleepiness related to the use of direct dopaminergic agonists may improve with dosage reduction or discontinuation. Stimulants such as modafinil may provide modest benefit.
引用
收藏
页码:215 / 221
页数:6
相关论文
共 159 条
  • [1] Hely M.A.(2005)Sydney Multicenter Study of Parkinson’s disease: non—L-doparesponsive problems dominate at 15 years Mov Disord 20 190-199
  • [2] Morris J.G.(2002)Sleep disorders in Parkinson’s disease Mov Disord 17 775-781
  • [3] Reid W.G.(2003)Sleepiness in Parkinson’s disease: a controlled study Mov Disord 18 668-672
  • [4] Trafficante R.(2006)The range and nature of sleep dysfunction in untreated Parkinson’s disease (PD). A comparative controlled clinical study using the Parkinson’s disease sleep scale and selective polysomnography J Neurol Sci 248 158-162
  • [5] Kumar S.(2007)Hypocretin (orexin) cell loss in Parkinson’s disease Brain 130 1586-1595
  • [6] Bhatia M.(2004)Lewy body-related α-synucleinopathy in the aged human brain J Neural Transm 111 1219-1235
  • [7] Behari M.(2006)Excessive daytime sleepiness in Parkinson disease: Is it the drugs or the disease? Neurology 67 853-858
  • [8] Brodsky M.A.(1999)Excessive daytime sleepiness and sleep benefit in Parkinson’s disease: a community-based study Mov Disord 14 922-927
  • [9] Godbold J.(2006)Excessive daytime sleepiness in patients with Parkinson’s disease: a polysomnography study Mov Disord 21 1432-1438
  • [10] Roth T.(2003)Assessment of sleepiness and unintended sleep in Parkinson’s disease patients taking dopamine agonists Sleep Med 4 275-280